Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value

doi:10.7249/RR308

GSTDTAP > 资源环境科学

DOI	10.7249/RR308
报告编号	RR-308
	Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value
	Steven Garber; Susan M. Gates; Emmett B. Keeler; Mary E. Vaiana; Andrew W. Mulcahy; Christopher Lau; Arthur L. Kellermann
	2014
出版年	2014
页数	130
语种	英语
国家	美国
出版者	RAND Corporation
领域	资源环境
英文摘要	New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases. The analysis synthesized information from peer-reviewed and other literature, a panel of technical advisors convened for the project, and 50 one-on-one expert interviews. The authors also conducted case studies of eight medical products. The following features of the U.S. health care environment tend to increase spending without also conferring major health benefits: lack of basic scientific knowledge about some disease processes, costs and risks of U.S. Food and Drug Administration (FDA) approval, limited rewards for medical products that could lower spending, treatment creep, and the medical arms race.
英文关键词	United States Science, Technology and Innovation Policy Health Care Technology Health Care Costs Students
URL	查看原文
来源平台	Rand Corporation
引用统计
文献类型	科技报告
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/3945
专题	资源环境科学
推荐引用方式 GB/T 7714	Steven Garber,Susan M. Gates,Emmett B. Keeler,et al. Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value:RAND Corporation,2014.